Children with Ulcerative Colitis (UC). Ulcerative colitis
Conditions
Interventions
Intervention 1: Control group : In addition to the standard treatment (sulfasalazine), a volume equivalent of placebo syrup will be given daily for two months. Intervention 2: Intervention group: In a
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
6 Years to 18 Years
Inclusion criteria
Inclusion criteria: Children 6-18 years old who , according to the ESPHAN Guideline , have mild to moderate active Ulcerative Colitis Obtain informed consent from the patient/ patient's parents
Exclusion criteria
Exclusion criteria: Child with a history of underlying disease including heart, kidney, liver, biliary, gastrointestinal diseases (any gastrointestinal disease other than UC) simultaneously Taking anticoagulants such as warfarin or antiplatelet drugs by the patient Diabetic patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The Pediatric Ulcerative Colitis Activity Index (PUCAI). Timepoint: Assess the severity of the disease at baseline, at the end of the first month and at the end of the second month of treatment. Method of measurement: Stool exam and PUCAI questionnaires.;The Simple Clinical Colitis Activity Index (CSCCAI). Timepoint: Assess the severity of the disease at baseline, at the end of the first month and at the end of the second month of treatment. Method of measurement: Stool exam and CSCCAI questionnaires. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZinat Heidari
Mashhad University of Medical Sciences
Outcome results
None listed